Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control
Abstract Response to antihypertensive drugs in patients with chronic kidney disease (CKD) has great interindividual variability. Adrenomedullin (ADM) is produced abundantly in hypertension, but clearance is very rapid. Mid-regional proADM (MR-proADM) produced from an ADM precursor is considered a su...
Guardado en:
Autores principales: | Motoshi Iwao, Ryota Tanaka, Yosuke Suzuki, Takeshi Nakata, Kohei Aoki, Akihiro Fukuda, Naoya Fukunaga, Ryosuke Tatsuta, Keiko Ohno, Hirotaka Shibata, Hiroki Itoh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/23a40a1458d841bbb79e367f4c2dbd8c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MR-proADM as prognostic factor of outcome in COVID-19 patients
por: Emanuela Sozio, et al.
Publicado: (2021) -
Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department
por: Marilena Minieri, et al.
Publicado: (2021) -
Mid-Regional Proadrenomedullin (MR-proADM) and Microcirculation in Monitoring Organ Dysfunction of Critical Care Patients With Infection: A Prospective Observational Pilot Study
por: Roberta Domizi, et al.
Publicado: (2021) -
A case of improvement of clozapine-induced low leukocyte counts by adenine, cepharanthin and ninjin-yoei-to in a patient with treatment-resistant schizophrenia
por: Shintaro Kamei, et al.
Publicado: (2021) -
ADME-Space: a new tool for medicinal chemists to explore ADME properties
por: Giovanni Bocci, et al.
Publicado: (2017)